Barclays’s Constellium CSTM Stock Holding History

Barclays’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,000	Closed	-$160K	–	6976
2019 Q1	$160K	Buy	+20,000	New	+$171K	﹤0.01%	4991

Other funds holding CSTM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Barclays's CSTM Position: Q1 2026 in Review

Barclays reduced its Constellium (CSTM) stake by 39% in Q1 2026, selling an estimated $2.67M and leaving 172,928 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1918.

Barclays first reported a position in CSTM in Q2 2013 and has held it in 37 quarters since. The position peaked at $8.67M in Q1 2014. 313 funds tracked by Wall St. Rank hold CSTM as of Q1 2026.

Barclays held 172,928 shares of Constellium worth $4.25M as of Q1 2026.
Barclays sold 112,118 Constellium shares in Q1 2026, an estimated $2.67M.
Constellium made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1918 holding.
Barclays first reported a position in Constellium in Q2 2013 and has held it in 37 quarters since.
Barclays's Constellium position peaked at $8.67M in Q1 2014.
313 funds tracked by Wall St. Rank held Constellium as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.